These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs. Barthélémy I; Barrey E; Aguilar P; Uriarte A; Le Chevoir M; Thibaud JL; Voit T; Blot S; Hogrel JY BMC Musculoskelet Disord; 2011 Apr; 12():75. PubMed ID: 21489295 [TBL] [Abstract][Full Text] [Related]
3. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies. Nguyen F; Cherel Y; Guigand L; Goubault-Leroux I; Wyers M J Comp Pathol; 2002; 126(2-3):100-8. PubMed ID: 11944998 [TBL] [Abstract][Full Text] [Related]
4. Microvessel density in muscles of dogs with golden retriever muscular dystrophy. Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137 [TBL] [Abstract][Full Text] [Related]
5. Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis. Fraysse B; Barthélémy I; Qannari EM; Rouger K; Thorin C; Blot S; Le Guiner C; Chérel Y; Hogrel JY BMC Musculoskelet Disord; 2017 Apr; 18(1):153. PubMed ID: 28403854 [TBL] [Abstract][Full Text] [Related]
6. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements. Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Grange RW Methods Mol Biol; 2011; 709():105-23. PubMed ID: 21194024 [TBL] [Abstract][Full Text] [Related]
7. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures. Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR Skelet Muscle; 2016; 6():14. PubMed ID: 27047655 [TBL] [Abstract][Full Text] [Related]
8. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength. Ambrósio CE; Valadares MC; Zucconi E; Cabral R; Pearson PL; Gaiad TP; Canovas M; Vainzof M; Miglino MA; Zatz M Neuromuscul Disord; 2008 Nov; 18(11):892-3. PubMed ID: 18667316 [No Abstract] [Full Text] [Related]
9. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog. Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604 [TBL] [Abstract][Full Text] [Related]
10. Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy. Gaiad TP; Silva MB; Silva GC; Caromano FA; Miglino MA; Ambrósio CE Res Vet Sci; 2011 Oct; 91(2):188-93. PubMed ID: 21315399 [TBL] [Abstract][Full Text] [Related]
11. A normal life without muscle dystrophin. Zatz M; Vieira NM; Zucconi E; Pelatti M; Gomes J; Vainzof M; Martins-Bach AB; Garcia Otaduy MC; Bento dos Santos G; Amaro E; Landini V; Andrade T Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920 [TBL] [Abstract][Full Text] [Related]
12. Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy. Barthélémy I; Uriarte A; Drougard C; Unterfinger Y; Thibaud JL; Blot S PLoS One; 2012; 7(11):e48478. PubMed ID: 23185260 [TBL] [Abstract][Full Text] [Related]